STOCK TITAN

CBD LIFE SCIENCES INC - CBDL STOCK NEWS

Welcome to our dedicated page for CBD LIFE SCIENCES news (Ticker: CBDL), a resource for investors and traders seeking the latest updates and insights on CBD LIFE SCIENCES stock.

CBD Life Sciences Inc. (CBDL) is a company focused on identifying, evaluating, and exploiting opportunities in the CBD space. Led by CEO Lisa Nelson, the company recently underwent a reverse split to rebrand its CBD products and launch a new product website. The rebranding is near completion, with an expected launch in mid-May 2024. CBDL aims to drive sales growth through wholesale and retail channel partnerships, with a full line of hemp-based organic products including CBD drops, pain relief creams, anxiety and sleep supplements, gummies, cartridges, and a pet line.

Rhea-AI Summary

CBD Life Sciences (OTC PINK: CBDL) has outlined key developments for 2021 following the legalization of recreational cannabis in Arizona. The company plans to participate in trade shows and install vending machines to increase revenue. It aims to expand its market by selling hemp products on Amazon after securing a trademark for LBC Bioscience Inc.. Additionally, CBD Life Sciences is exploring cultivation opportunities in Arizona’s new market. Anticipated product launches and a robust online store are set to enhance their revenue streams significantly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK: CBDL) has announced the launch of its new Delta-10 Cartridges through subsidiary LBC Bioscience Inc. These cartridges are available in two strains: Sour Diesel and Blue Dream, both featuring 900MG of Delta-10. CEO Lisa Nelson reported strong sales of Delta-8 products and anticipates high demand for Delta-10, aiming to enhance their existing product line. The company is positioning itself to capitalize on Arizona's new recreational cannabis market and has identified potential cultivation sites.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.7%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences Inc. (OTC PINK:CBDL) announced its commitment to product purity by partnering with EVIO Labs for ISO 17025 accredited testing. The new testing services will cater to manufacturers, retailers, and consumers, ensuring safety with a comprehensive CBD Safety Panel. This includes tests for cannabinoid profiles, pesticides, heavy metals, and more. CEO Lisa Nelson emphasized the growing demand for tested hemp products, which could increase business opportunities. Additionally, the company is pursuing cultivation opportunities in Arizona’s recreational cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.04%
Tags
none
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) announced its entry into the Kosher Market through its subsidiary, LBC Bioscience Inc. The company plans to introduce products such as CBD Gummies, CBD Mints, and CBD Enriched Tea. CEO Lisa Nelson highlighted a growing customer demand for kosher products, which aims to expand their market reach significantly. Kosher certification is a rising trend in the food industry, with the kosher market valued at $17 billion and growing at an annual rate of 15%. CBD Life Sciences is also exploring cultivation sites in Arizona's expanding recreational cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.41%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) announced significant corporate developments, including the grand opening of its 2nd retail location and a distribution center in March 2021. A potential 3rd location in Sedona is also planned. The company introduced a vending machine for product sales in a convenience store. President & CEO Lisa Nelson reported outstanding early-year revenue and teased five new product launches, with plans to sell on Amazon. The firm is pursuing new cultivation opportunities in Arizona's recreational cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) announced the launch of a new hemp skincare line through its subsidiary, LBC Bioscience Inc. The lineup includes five products: Lavender & Chamomile Toner, Hyaluronic Acid Anti-Aging Serum, Vitamin C Brightening Creme, Nourishing Eye Creme, and Green Tea Facial Cleanser. CEO Lisa Nelson expressed optimism about expanding into retail locations and possibly QVC. CBD's benefits for skin health were emphasized, highlighting its moisturizing properties and anti-aging effects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.03%
Tags
none
Rhea-AI Summary

CBD Life Sciences (OTC PINK: CBDL) is in the final stages of launching its hemp products on Amazon. This strategic move aims to tap into the booming health and wellness market, with a focus on organic and kosher offerings like Pain Relief Cream and Anxiety Tinctures. The CEO, Lisa Nelson, projects significant revenue growth from this venture, leveraging the competitive advantage of their certified products. Additionally, the company is exploring opportunities in Arizona's recreational cannabis market, enhancing its growth potential and product distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
45.08%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) announced a Letter of Understanding regarding a lease for a hemp farm in Arizona through its subsidiary, LBC Bioscience Inc. The agreement is expected to be finalized within a week, enhancing the company's revenue and production capabilities. CEO Lisa Nelson highlighted the potential for growth and increased product exposure. LBC already offers a wide array of CBD products, including bath bombs and oils, with upcoming holiday sales and promotions. The hemp industry boasts over 25,000 uses, presenting significant growth opportunities for the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.71%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK: CBDL) announced the launch of new CBD Flower products through its subsidiary, LBC Bioscience Inc. The two strains introduced are Hawaiian Haze, recognized for its tropical flavor profile, and Sour Space Candy, noted for its unique candied apple taste. These products promise various health benefits, including support for neurological and behavioral conditions, pain management, and gastrointestinal disorders. With ongoing holiday promotions and a broad product line, LBC aims to enhance customer engagement and sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
none
Rhea-AI Summary

CBD Life Sciences Inc. (OTC PINK:CBDL) announces the launch of new 100 MG CBD Bath Bombs, available in six colors and scents. These bath bombs contain 100mg of pure CBD Isolate, enriched with essential oils and minerals designed to promote relaxation, relieve stress and pain, and enhance overall health. The products are crafted by LBC Bioscience, ensuring high quality through certified GMP standards and third-party testing. The bath bombs are now available for purchase, with additional seasonal scents expected soon.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of CBD LIFE SCIENCES (CBDL)?

The current stock price of CBD LIFE SCIENCES (CBDL) is $0.0004 as of December 20, 2024.

What is the market cap of CBD LIFE SCIENCES (CBDL)?

The market cap of CBD LIFE SCIENCES (CBDL) is approximately 1.4M.

What is CBD Life Sciences Inc. focused on?

CBD Life Sciences Inc. is focused on identifying, evaluating, and exploiting opportunities in the CBD space.

Who is the CEO of CBD Life Sciences Inc.?

The CEO of CBD Life Sciences Inc. is Lisa Nelson.

What recent change did CBD Life Sciences Inc. undergo?

CBD Life Sciences Inc. recently underwent a reverse split to rebrand its CBD products and launch a new product website.

When is the expected launch of the rebranded products?

The expected launch of the rebranded products is in mid-May 2024.

What products does CBD Life Sciences Inc. offer?

CBD Life Sciences Inc. offers a full line of hemp-based organic products, including CBD drops, pain relief creams, anxiety and sleep supplements, gummies, cartridges, and a pet line.

How does CBD Life Sciences Inc. plan to drive sales growth?

CBD Life Sciences Inc. plans to drive sales growth through wholesale and retail channel partnerships.

Where can shareholders and investors follow CBD Life Sciences Inc. for news and updates?

Shareholders, investors, and business partners can follow CBD Life Sciences Inc. on X: @cbdlifescience for news and updates.

What is the Safe Harbor Statement of CBD Life Sciences Inc.?

The Safe Harbor Statement of CBD Life Sciences Inc. states that forward-looking statements are based on current beliefs, expectations, and assumptions regarding the future.

How does CBD Life Sciences Inc. approach its ultimate objective of increasing shareholder value?

CBD Life Sciences Inc. approaches its ultimate objective of increasing shareholder value by seeking additional opportunities within the CBD sector.

Where can interested parties find more information about CBD Life Sciences Inc.?

Interested parties can find more information about CBD Life Sciences Inc. in its filings with the Securities and Exchange Commission and quarterly disclosure report on the OTC Markets.

CBD LIFE SCIENCES INC

OTC:CBDL

CBDL Rankings

CBDL Stock Data

1.39M
141.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Scottsdale